GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs

The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, announced a $67 million investment in the life sciences sector through the Life Sciences Fund. These investments will drive economic growth, strengthen health resilience and advance Canada’s dual-use industrial capacity.

Avivo Biomedical Inc. will receive up to $10.9 million toward its $33.9 million project that will advance the development of its technology to expand blood transfusion and organ transplant capabilities. Its platform converts different blood types into Type O (including O negative, the universal donor type), making more transfusion and transplant options available to more patients.

Read the full Government of Canada announcement

Related news:

• GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs